Sfoglia per Autore
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1
1992 Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; Stirpe F.; Gobbi M.
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
1992 Falini B.; Flenghi L.; Aversa F.; Barbabietola G.; Martelli M.F.; Comeli P.; Tazzari P.L.; Broe M.K.; Stein H.; Durkop H.; Pizzolo G.; Bolognesi A.; Stirpe F.; Sabattini E.; Pileri S.
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation
1992 Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.; Stein H.; Flenghi L.; Martelli M.F.; Stirpe F.
Observer variation in histological assessment of Helicobacter pylori on gastric biopsies [6]
1996 Biasco G.; Paganelli G.M.; Terranova A.; Santucci R.; Renga M.; Vaira D.; Amorosi A.; Pileri S.
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
1996 Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B.; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B.
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
1999 Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.; Gobbi M.; Stirpe F.
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma
2002 Caletti G.; Zinzani P.L.; Fusaroli P.; Buscarini E.; Parente F.; Federici T.; Peyre S.; De Angelis C.; Bonanno G.; Togliani T.; Pileri S.; Tura S.
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
2003 Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Polito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B.
Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy
2003 Caletti G.; Togliani T.; Fusaroli P.; Sabattini E.; Khodadadian E.; Gamberi B.; Gobbi M.; Pileri S.
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma
2004 ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA
CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation.
2004 Bellan C.; De Falco G.; Lazzi S.; Micheli P.; Vicidomini S.; Schürfels K.; Amato T.; Palumbo A.; Bagella L.; Sabattini E.; Bartolommei S.; Hummel M.; Pileri S.; Tosi P.; Leoncini L.; Giordano A.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.
2004 WENT P; ASCANI S; STROM E; BRORSON SH; MUSSO M; ZINZANI P.; FALINI B; DIRNHOFER S; PILERI S.
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma.
2004 Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M.
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease.
2004 Marafioti T.; Mancini C.; Ascani S.; Sabattini E.; Zinzani P.L.; Pozzobon M.; Pulford K.; Falini B.; Jaffe E.S.; Müller-Hermelink H.K.; Mason D.Y.; Pileri S.A.
Specific recognition of the viral protein UL18 by CD85/LIR-1/ITL2 on T cells mediates the non-MHC-restricted lysis of human cytomegalovirus infected cells.
2004 Saverino D.; Ghiotto; F.; Merlo; A.; Bruno S.; Battini L.; Occhino M.; Maffei M.; Tenca C.; Pileri S.; Baldi L.; Fabbi M.; Bachi A.; De Santanna A.; Grossi C.; Ciccone E.
Acute renal failure in a young woman with Fisher-Evans’ syndrome.
2004 De Sanctis B.A.; Mandrealo M.; Poggi C.; Pileri S.; Casanova S.; Santoro A.
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
Simple diagnostic assay for hairy cell leukemia by cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1).
2004 FALINI B.; TIACCI E.; LISO A.; BASSO K.; SABATTINI E.; PACINI R.; FOA R.; PULSONI A.; DALLA FAVERA R.; PILERI S.A.
Aberrant promoter methylation of multiple genes thoughout the clinico-pathologic spectrum of B-cell neoplastia.
2004 Rossi D.; Capello D.; Gloghini A.; Franceschetti S.; Paulli M.; Bhatia K.; Saglio G.; Vitolo U.; Pileri S.A.; Esteller M.; Carbone A.; Gaidano G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 | Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; S...tirpe F.; Gobbi M. | 1992-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin | Falini B.; Flenghi L.; Aversa F.; Barbabietola G.; Martelli M.F.; Comeli P.; Tazzari P.L.; Broe M....K.; Stein H.; Durkop H.; Pizzolo G.; Bolognesi A.; Stirpe F.; Sabattini E.; Pileri S. | 1992-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation | Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.;... Stein H.; Flenghi L.; Martelli M.F.; Stirpe F. | 1992-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Observer variation in histological assessment of Helicobacter pylori on gastric biopsies [6] | Biasco G.; Paganelli G.M.; Terranova A.; Santucci R.; Renga M.; Vaira D.; Amorosi A.; Pileri S. | 1996-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice | Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B....; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B. | 1996-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins | Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.;... Gobbi M.; Stirpe F. | 1999-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma | Caletti G.; Zinzani P.L.; Fusaroli P.; Buscarini E.; Parente F.; Federici T.; Peyre S.; De Angeli...s C.; Bonanno G.; Togliani T.; Pileri S.; Tura S. | 2002-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells | Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Pol...ito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B. | 2003-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy | Caletti G.; Togliani T.; Fusaroli P.; Sabattini E.; Khodadadian E.; Gamberi B.; Gobbi M.; Pileri S. | 2003-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma | ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA | 2004-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation. | Bellan C.; De Falco G.; Lazzi S.; Micheli P.; Vicidomini S.; Schürfels K.; Amato T.; Palumbo A.; ...Bagella L.; Sabattini E.; Bartolommei S.; Hummel M.; Pileri S.; Tosi P.; Leoncini L.; Giordano A. | 2004-01-01 | JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. | WENT P; ASCANI S; STROM E; BRORSON SH; MUSSO M; ZINZANI P.; FALINI B; DIRNHOFER S; PILERI S. | 2004-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. | Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani... M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease. | Marafioti T.; Mancini C.; Ascani S.; Sabattini E.; Zinzani P.L.; Pozzobon M.; Pulford K.; Falini ...B.; Jaffe E.S.; Müller-Hermelink H.K.; Mason D.Y.; Pileri S.A. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Specific recognition of the viral protein UL18 by CD85/LIR-1/ITL2 on T cells mediates the non-MHC-restricted lysis of human cytomegalovirus infected cells. | Saverino D.; Ghiotto; F.; Merlo; A.; Bruno S.; Battini L.; Occhino M.; Maffei M.; Tenca C.; Piler...i S.; Baldi L.; Fabbi M.; Bachi A.; De Santanna A.; Grossi C.; Ciccone E. | 2004-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Acute renal failure in a young woman with Fisher-Evans’ syndrome. | De Sanctis B.A.; Mandrealo M.; Poggi C.; Pileri S.; Casanova S.; Santoro A. | 2004-01-01 | JN. JOURNAL OF NEPHROLOGY | - | 1.01 Articolo in rivista | - |
| Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine | ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Simple diagnostic assay for hairy cell leukemia by cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). | FALINI B.; TIACCI E.; LISO A.; BASSO K.; SABATTINI E.; PACINI R.; FOA R.; PULSONI A.; DALLA FAVER...A R.; PILERI S.A. | 2004-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| Aberrant promoter methylation of multiple genes thoughout the clinico-pathologic spectrum of B-cell neoplastia. | Rossi D.; Capello D.; Gloghini A.; Franceschetti S.; Paulli M.; Bhatia K.; Saglio G.; Vitolo U.; ...Pileri S.A.; Esteller M.; Carbone A.; Gaidano G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile